Basic Sciencemoderate evidence

Chiral nanoparticles drive enantiomer-specific osteogenic differentiation of stem cells and accelerate bone regeneration.

Science advances·June 12, 2026·PMID 42268950

Why it matters

Controlling stem cell fate is a central challenge in regenerative medicine. This work demonstrates that nanoparticle chirality can enantioselectively enhance osteogenesis and angiogenesis, offering a new material-based strategy to improve bone graft substitutes and scaffold design without exogenous growth factors.

Infographic summary of Chiral nanoparticles drive enantiomer-specific osteogenic differentiation of stem cells and accelerate bone regeneration.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled